देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
MOXIDECTIN, PRAZIQUANTEL
Continental Farmaceutica
QP54AB52
MOXIDECTIN, PRAZIQUANTEL
19.5/121.7
Oral Gel
LM-Licensed Merchant
Equine - Food
Moxidectin, combinations
Endectoparasiticides
Authorised
2014-03-28
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Equipramox 19.5 mg/g + 121.7 mg/g oral gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral Gel. Pale yellow to orange/pink oral gel. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. Each g contains: Active substances Moxidectin 19.5 mg Praziquantel 121.7 mg Excipients Benzyl alcohol (E1519) 220.0 mg Butylhydroxytoluene (E321) 0.8 mg For the full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/12/2016_ _CRN 7025200_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In horses: For the treatment of mixed cestodes and nematodes or arthropods infections, caused by moxidectin and praziquantel sensitive strains of: Large strongyles: _Strongylus vulgaris _(adult stages) _Strongylus edentatus _(adult stages) _Triodontophorus brevicauda _(adults) _Triodontophorus serratus _(adults) _Triodontophorus tenuicollis _(adults) Small strongyles (adults and intraluminal larval stages): _._ _Cyathostomum _spp _Cylicocyclus _spp _Cylicostephanus _spp _Cylicodontophorus _spp _Gyalocephalus _spp Ascarids: _Parascaris equorum _(adults) Other species: _Oxyuris equi _(adult stages) _Habronema muscae _(adults) _Gasterophilus intestinalis _(L2, L3) _Gasterophilus nasalis _(L2, L3) _Strongyloides westeri _(adults) _Trichostrongylus axei (_adult stages_)_ Tapeworm (adults): _._ _Anoplocephala perfoliata_ _._ _Anoplocephala magna_ _._ _Paranoplocephala mammillana_ The egg reappearance period of small strongyles is 90 days. The product is effective against (developing) intramucosal L4 stages of small strongyles. At 8 weeks after treatment, early (hypobiotic) EL3 stages of small strongyles are eliminated. 4.3 C पूरा दस्तावेज़ पढ़ें